Artes Medical rises after reporting increase in product sales

San Diego-based firm Artes Medical, Inc. (Nasdaq:ARTE) is up 8% in morning trading after reporting early Monday that it expects second-quarter revenue of $3.2 million from its flagship product ArteFill, which is used for the correction of smile lines. The sales total would represent a 56% year-over-year increase for the second quarter. “The strong growth in ArteFill sales during the second quarter reflects the impact of our recently expanded 42-person sales force, our increasing consumer initiatives and a growing acceptance of ArteFill by physicians,” Christopher Reinhard, Artes Medical’s executive chairman, said in a statement. “We believe it also demonstrates the accelerating patient excitement over the truly long-lasting results that ArteFill provides.”

For access to the full article, you must be a registered member - it's FREE.

Already a member? Please log in below